)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Surgical Science
Surgical Science (SUS) investor relations material
Surgical Science Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary12 Nov, 2026
Executive summary
Q3 net sales were SEK 260.2m, down 1% YoY; adjusted EBIT was SEK 37.8m, up 15%, with a 15% margin. Gross margin rose to 68%.
9M sales grew 4% reported and 5% in local currencies; adjusted EBIT was SEK 104.3m versus SEK 46.1m.
Financial targets are expected to be reached in 2027; 2026 growth remains below target.
Financial highlights
Q3 sales were SEK 260.2m versus SEK 263.6m; net profit was SEK 34.1m versus SEK 20.4m.
Adjusted EBIT was SEK 37.8m versus SEK 32.8m, with a 15% reported margin and 17% FX-adjusted margin.
Reported EBIT was SEK 32.0m versus SEK 27.2m; FX-adjusted EBIT was SEK 39.1m, a 15% margin.
Q3 gross margin rose to 68% from 65%; operating cash flow was SEK 42.5m versus negative SEK 4.4m in Q3 2025.
9M operating cash flow was SEK 123.1m versus SEK 6.9m; net profit was SEK 73.6m versus SEK 33.6m.
Outlook and guidance
Financial targets are annual growth of 10–15% and adjusted EBIT margin of at least 15%; management expects targets to be met in 2027, with 2026 growth and profitability below target.
Educational Products entered Q4 with a good order backlog and pipeline; demand outlook was positive for EMEA and educational products.
Aeris deliveries began in Q4 2026; significant shipment volumes are expected from Q1 2027, with sales contribution growing through 2027.
Revenue loss related to the cancelled MoU/Intuitive license is expected below the previously indicated SEK 60m–SEK 90m range; renewal outcomes remain uncertain.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Surgical Science
- Q2 2026 revenue up 22%, EBIT margin 15%, and license revenue surged 44%.SUS
Q2 2026 - Strong cash flow and 12% EBIT margin offset FX-driven sales decline; EMEA and Ultrasound excelled.SUSQ1 2026
- Q4 delivered 15% local sales growth and record license revenue, but 2026 faces contract headwinds.SUSQ4 2025
- Targets 10–15% annual growth, >15% EBIT, and Nasdaq Main Market listing by 2027.SUSCMD 2025
- Acquisition doubles ultrasound simulation sales and global reach, unlocking major synergies.SUSM&A announcement
- Q3 sales up 10%, margins strong, and Industry/OEM led growth with robust cash position.SUSQ3 2024
- Q2 sales fell 2% as Educational Products declined and Industry/OEM grew 15%, with strong cash position.SUSQ2 2024
- Sales up 33% and license revenues hit record high; 2026 targets revised amid regulatory delays.SUSQ1 2025
- Record Q4 sales, key acquisitions, and new agreements drive long-term growth outlook.SUSQ4 2024
Next Surgical Science earnings date
Q4 202623 Feb, 2027
Surgical Science
Next Surgical Science earnings date
Q4 202623 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Surgical Science AB is a Swedish medical technology company that develops and markets VR-based simulators for evidence-based training of surgical skills. The company has developed several simulators for virtual training for specific surgical procedures. The training modules do not replace the traditional education and training, but serve to supplement the procedural and technical parts of surgery. The goal of the training modules is to create a “real feel” to the simulation, thus creating an ideal platform for development of skills before operating on live patients. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden.